The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...
An analysis of CIRDC, dissecting the polymicrobial nature of the syndrome and outlining standards for diagnostic testing.
The FDA approved a new 300 mg/2 mL dose of Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of four allergic and ...
NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly-owned subsidiary Good Salt Life, Inc., a pioneer in innovative surface ...
Redd’s daily treatment reveals how orangutans with chronic respiratory diseases are adapting to use certain medical tools ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback